Literature DB >> 14551703

A novel, alternative pathway of apoptosis triggered through class II major histocompatibility complex molecules.

Zoltan A Nagy1, Nuala A Mooney.   

Abstract

Major histocompatibility complex class II (MHC-II) molecules, in addition to their role of presenting antigen to T lymphocytes, can serve as receptors triggering programmed cell death. MHC-II induced cell death affects activated/tumour transformed cells selectively, and it proceeds without the involvement of caspases, the major proteases of classical apoptosis. Caspase-independent programmed cell death can also be triggered, albeit less effectively, via a series of other cell surface molecules. Here, we discuss the major characteristics, physiological significance, and clinical relevance of caspase-independent apoptotic pathways with particular emphasis on the one induced by MHC-II ligation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14551703     DOI: 10.1007/s00109-003-0489-9

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  65 in total

1.  X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II.

Authors:  A Dessen; C M Lawrence; S Cupo; D M Zaller; D C Wiley
Journal:  Immunity       Date:  1997-10       Impact factor: 31.745

2.  Intracellular events associated with inhibition of B cell activation by monoclonal antibodies to HLA class II antigens.

Authors:  H Holte; H K Blomhoff; K Beiske; S Funderud; P Torjesen; G Gaudernack; T Stokke; E B Smeland
Journal:  Eur J Immunol       Date:  1989-07       Impact factor: 5.532

3.  Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma.

Authors:  J M Vose; B K Link; M L Grossbard; M Czuczman; A Grillo-Lopez; P Gilman; A Lowe; L A Kunkel; R I Fisher
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

4.  Growth inhibition of Epstein-Barr virus-transformed B cells by anti-HLA-DR antibody L243: possible relationship to L243-induced down-regulation of CD23 antigen expression.

Authors:  D Kabelitz; O Janssen
Journal:  Cell Immunol       Date:  1989-04-15       Impact factor: 4.868

5.  Selective in vivo antitumor effects of monoclonal anti-I-A antibody on B cell lymphoma.

Authors:  S H Bridges; A M Kruisbeek; D L Longo
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

6.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.

Authors:  J H Brown; T S Jardetzky; J C Gorga; L J Stern; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1993-07-01       Impact factor: 49.962

7.  CD4+ CD8+ thymocytes are preferentially induced to die following CD45 cross-linking, through a novel apoptotic pathway.

Authors:  S Lesage; A M Steff; F Philippoussis; M Pagé; S Trop; V Mateo; P Hugo
Journal:  J Immunol       Date:  1997-11-15       Impact factor: 5.422

8.  HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes.

Authors:  J P Truman; C Choqueux; J Tschopp; J Vedrenne; F Le Deist; D Charron; N Mooney
Journal:  Blood       Date:  1997-03-15       Impact factor: 22.113

9.  MHC class II and CD40 play opposing roles in dendritic cell survival.

Authors:  A McLellan; M Heldmann; G Terbeck; F Weih; C Linden; E B Bröcker; M Leverkus; E Kämpgen
Journal:  Eur J Immunol       Date:  2000-09       Impact factor: 5.532

10.  The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins.

Authors:  I Marzo; C Brenner; N Zamzami; S A Susin; G Beutner; D Brdiczka; R Rémy; Z H Xie; J C Reed; G Kroemer
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

View more
  9 in total

1.  MHC class II structural requirements for the association with Igalpha/beta, and signaling of calcium mobilization and cell death.

Authors:  Lei Jin; John C Stolpa; Ryan M Young; Aimee E Pugh-Bernard; Yosef Refaeli; John C Cambier
Journal:  Immunol Lett       Date:  2007-12-26       Impact factor: 3.685

2.  Induction of apoptosis by cross-linking antibodies bound to human B-lymphoma cells: expression of Annexin V binding sites on the antibody cap.

Authors:  M Jules Mattes; Rosana B Michel; David M Goldenberg; Robert M Sharkey
Journal:  Cancer Biother Radiopharm       Date:  2009-04       Impact factor: 3.099

3.  MPYS, a novel membrane tetraspanner, is associated with major histocompatibility complex class II and mediates transduction of apoptotic signals.

Authors:  Lei Jin; Paul M Waterman; Karen R Jonscher; Cindy M Short; Nichole A Reisdorph; John C Cambier
Journal:  Mol Cell Biol       Date:  2008-06-16       Impact factor: 4.272

4.  Characterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases the potency of rituximab.

Authors:  Rhona Stein; Zhengxing Qu; Susan Chen; David Solis; Hans J Hansen; David M Goldenberg
Journal:  Blood       Date:  2006-06-15       Impact factor: 22.113

Review 5.  Killing tumor cells through their surface beta(2)-microglobulin or major histocompatibility complex class I molecules.

Authors:  Jing Yang; Qing Yi
Journal:  Cancer       Date:  2010-04-01       Impact factor: 6.860

6.  Characterization of antibody-containing vesicles shed from B-lymphoma cell lines: exposure of annexin V binding sites.

Authors:  Rosana B Michel; Mones Abu-Asab; Maria Tsokos; M Jules Mattes
Journal:  Leuk Lymphoma       Date:  2006-11

7.  Transcriptome-based biomarker gene screening and evaluation of the extracellular fatty acid-binding protein (Ex-FABP) on immune and angiogenesis-related genes in chicken erythrocytes of tibial dyschondroplasia.

Authors:  Ali Raza Jahejo; Sayyad Ali Raza Bukhari; Nasir Rajput; Nazeer Hussain Kalhoro; Imdad Hussain Leghari; Sayed Haidar Abbas Raza; Zhen Li; Wen-Zhong Liu; Wen-Xia Tian
Journal:  BMC Genomics       Date:  2022-04-22       Impact factor: 4.547

Review 8.  B cell MHC class II signaling: A story of life and death.

Authors:  Divya Sai Katikaneni; Lei Jin
Journal:  Hum Immunol       Date:  2018-04-30       Impact factor: 2.850

9.  Disparate effects of acute and chronic infection with SIVmac239 or SHIV-89.6P on macaque plasmacytoid dendritic cells.

Authors:  R Keith Reeves; Patricia N Fultz
Journal:  Virology       Date:  2007-05-08       Impact factor: 3.616

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.